129 related articles for article (PubMed ID: 30624931)
21. Inositol polyphosphate multikinase modulates redox signaling through nuclear factor erythroid 2-related factor 2 and glutathione metabolism.
Tyagi R; Chakraborty S; Tripathi SJ; Jung IR; Kim SF; Snyder SH; Paul BD
iScience; 2023 Jul; 26(7):107199. PubMed ID: 37456841
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological evaluation of flavonoid-based IP6K2 inhibitors.
Ahn M; Park SE; Choi J; Choi J; Choi D; An D; Jeon H; Oh S; Lee K; Kim J; Jang J; Kim S; Byun Y
J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2193866. PubMed ID: 37013838
[TBL] [Abstract][Full Text] [Related]
23. Eriodictyol Suppresses Gastric Cancer Cells via Inhibition of PI3K/AKT Pathway.
Shan H; Zhang X; Mi Y; Jia J; Wang B; Yang Q
Pharmaceuticals (Basel); 2022 Nov; 15(12):. PubMed ID: 36558929
[TBL] [Abstract][Full Text] [Related]
24. TNP Analogues Inhibit the Virulence Promoting IP
Desmarini D; Truong D; Wilkinson-White L; Desphande C; Torrado M; Mackay JP; Matthews JM; Sorrell TC; Lev S; Thompson PE; Djordjevic JT
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291735
[TBL] [Abstract][Full Text] [Related]
25. Development of Novel IP6K Inhibitors for the Treatment of Obesity and Obesity-Induced Metabolic Dysfunctions.
Zhou Y; Mukherjee S; Huang D; Chakraborty M; Gu C; Zong G; Stashko MA; Pearce KH; Shears SB; Chakraborty A; Wang H; Wang X
J Med Chem; 2022 May; 65(9):6869-6887. PubMed ID: 35467861
[TBL] [Abstract][Full Text] [Related]
26. Whole Body
Ghoshal S; Mukherjee S; Chakraborty M; Msengi EN; Haubner J; Chakraborty A
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216174
[TBL] [Abstract][Full Text] [Related]
27. Identification of Small Molecule Inhibitors of RNase L by Fragment-Based Drug Discovery.
Tang J; Dong B; Liu M; Liu S; Niu X; Gaughan C; Asthana A; Zhou H; Xu Z; Zhang G; Silverman RH; Huang H
J Med Chem; 2022 Jan; 65(2):1445-1457. PubMed ID: 34841869
[TBL] [Abstract][Full Text] [Related]
28. Pleiotropic actions of IP6K1 mediate hepatic metabolic dysfunction to promote nonalcoholic fatty liver disease and steatohepatitis.
Mukherjee S; Chakraborty M; Ulmasov B; McCommis K; Zhang J; Carpenter D; Msengi EN; Haubner J; Guo C; Pike DP; Ghoshal S; Ford DA; Neuschwander-Tetri BA; Chakraborty A
Mol Metab; 2021 Dec; 54():101364. PubMed ID: 34757046
[TBL] [Abstract][Full Text] [Related]
29. Protein Adducts and Protein Oxidation as Molecular Mechanisms of Flavonoid Bioactivity.
Joyner PM
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443698
[TBL] [Abstract][Full Text] [Related]
30. The enzymatic activity of inositol hexakisphosphate kinase controls circulating phosphate in mammals.
Moritoh Y; Abe SI; Akiyama H; Kobayashi A; Koyama R; Hara R; Kasai S; Watanabe M
Nat Commun; 2021 Aug; 12(1):4847. PubMed ID: 34381031
[TBL] [Abstract][Full Text] [Related]
31. Flavonoids on diabetic nephropathy: advances and therapeutic opportunities.
Hu Q; Qu C; Xiao X; Zhang W; Jiang Y; Wu Z; Song D; Peng X; Ma X; Zhao Y
Chin Med; 2021 Aug; 16(1):74. PubMed ID: 34364389
[TBL] [Abstract][Full Text] [Related]
32. Inositol Polyphosphate Multikinase Signaling: Multifaceted Functions in Health and Disease.
Lee B; Park SJ; Hong S; Kim K; Kim S
Mol Cells; 2021 Apr; 44(4):187-194. PubMed ID: 33935040
[TBL] [Abstract][Full Text] [Related]
33. Identification of Small-Molecule Inhibitors of Human Inositol Hexakisphosphate Kinases by High-Throughput Screening.
Liao G; Ye W; Heitmann T; Ernst G; DePasquale M; Xu L; Wormald M; Hu X; Ferrer M; Harmel RK; Fiedler D; Barrow J; Wei H
ACS Pharmacol Transl Sci; 2021 Apr; 4(2):780-789. PubMed ID: 33860201
[TBL] [Abstract][Full Text] [Related]
34. Naphthylphthalamic acid associates with and inhibits PIN auxin transporters.
Abas L; Kolb M; Stadlmann J; Janacek DP; Lukic K; Schwechheimer C; Sazanov LA; Mach L; Friml J; Hammes UZ
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443187
[No Abstract] [Full Text] [Related]
35. Analysis of inositol phosphate metabolism by capillary electrophoresis electrospray ionization mass spectrometry.
Qiu D; Wilson MS; Eisenbeis VB; Harmel RK; Riemer E; Haas TM; Wittwer C; Jork N; Gu C; Shears SB; Schaaf G; Kammerer B; Fiedler D; Saiardi A; Jessen HJ
Nat Commun; 2020 Nov; 11(1):6035. PubMed ID: 33247133
[TBL] [Abstract][Full Text] [Related]
36. Unveiling the Properties of Thai Stingless Bee Propolis via Diminishing Cell Wall-Associated Cryptococcal Melanin and Enhancing the Fungicidal Activity of Macrophages.
Mamoon K; Thammasit P; Iadnut A; Kitidee K; Anukool U; Tragoolpua Y; Tragoolpua K
Antibiotics (Basel); 2020 Jul; 9(7):. PubMed ID: 32709077
[No Abstract] [Full Text] [Related]
37. Suramin and NF449 are IP5K inhibitors that disrupt inositol hexakisphosphate-mediated regulation of cullin-RING ligase and sensitize cancer cells to MLN4924/pevonedistat.
Zhang X; Shi S; Su Y; Yang X; He S; Yang X; Wu J; Zhang J; Rao F
J Biol Chem; 2020 Jul; 295(30):10281-10292. PubMed ID: 32493769
[TBL] [Abstract][Full Text] [Related]
38. Inositol Pyrophosphates: Signaling Molecules with Pleiotropic Actions in Mammals.
Lee S; Kim MG; Ahn H; Kim S
Molecules; 2020 May; 25(9):. PubMed ID: 32397291
[TBL] [Abstract][Full Text] [Related]
39. Identification of the Antidepressant Vilazodone as an Inhibitor of Inositol Polyphosphate Multikinase by Structure-Based Drug Repositioning.
Lee B; Park SJ; Lee S; Park SE; Lee E; Song JJ; Byun Y; Kim S
Mol Cells; 2020 Mar; 43(3):222-227. PubMed ID: 32209735
[TBL] [Abstract][Full Text] [Related]
40. Targeting the Inositol Pyrophosphate Biosynthetic Enzymes in Metabolic Diseases.
Mukherjee S; Haubner J; Chakraborty A
Molecules; 2020 Mar; 25(6):. PubMed ID: 32204420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
